MIAX:NYSEMiami International Holdings, Inc. Analysis
Data as of 2026-04-17 - not real-time
$44.85
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Miami International Holdings (MIAX) is trading at $44.85, well above its DCF fair value of roughly $19.6 and the forward P/E of 25.99 versus an industry average of 17.55, indicating a significant premium. Technical indicators show a bullish MACD crossover but an RSI hovering near 70, suggesting the stock is overbought, while volume is on a decreasing trend and the 20‑day SMA sits just below the current price, reinforcing a short‑term bearish bias. Price action is flirting with the calculated resistance around $45, with support near $37, limiting upside potential in the near term.
On the fundamentals side, MIAX posted a 14% revenue growth year‑over‑year and captured a record 18.2% share of the multi‑listed options market in Q4 2025, highlighting strong product momentum. The company’s cash position (~$478M) comfortably exceeds its modest debt load, yet profitability remains a challenge with a negative profit margin and a -11% ROE. While the firm operates in a low‑beta (0.68) environment, its 30‑day volatility exceeds 30%, and the capital‑markets sector carries medium regulatory exposure. Overall, the stock appears overvalued in the short run, but its growth trajectory and market‑share gains provide a rationale for a more neutral to cautiously optimistic stance over longer horizons.
On the fundamentals side, MIAX posted a 14% revenue growth year‑over‑year and captured a record 18.2% share of the multi‑listed options market in Q4 2025, highlighting strong product momentum. The company’s cash position (~$478M) comfortably exceeds its modest debt load, yet profitability remains a challenge with a negative profit margin and a -11% ROE. While the firm operates in a low‑beta (0.68) environment, its 30‑day volatility exceeds 30%, and the capital‑markets sector carries medium regulatory exposure. Overall, the stock appears overvalued in the short run, but its growth trajectory and market‑share gains provide a rationale for a more neutral to cautiously optimistic stance over longer horizons.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- RSI approaching overbought territory
- Price near resistance with decreasing volume
- Technical trend flagged as bearish
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong revenue growth and record market‑share gains
- Robust cash balance offsetting modest debt
- Valuation premium still present but upside potential of ~8% per DCF
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Continued expansion in multi‑asset exchange offerings
- Technology‑driven platform positioning for industry consolidation
- Potential for improved profitability as scale increases
Key Metrics & Analysis
Financial Health
Revenue Growth14.10%
Profit Margin-5.13%
P/E Ratio26.0
ROE-11.22%
ROA6.16%
Debt/Equity2.81
P/B Ratio4.4
Op. Cash Flow$167.8M
Free Cash Flow$55.7M
Industry P/E17.5
Technical Analysis
TrendBearish
RSI69.9
Support$37.10
Resistance$44.99
MA 20$40.50
MA 50$40.71
MA 200$41.64
MACDBullish
VolumeDecreasing
Fear & Greed Index89.39
Valuation
Fair Value$19.56
Target Price$48.40
Upside/Downside7.92%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.68
Volatility32.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.